Axiom Clinical Research

CLINICAL RESEARCH

ENROLLING STUDIES

Axiom is currently enrolling patients in Multiple Sclerosis and Alzheimer’s Disease studies.

Clipboard Picture Clipboard Picture

If you or a loved one would be interested in participating in a study for any of the listed fields, or if you would like more information on our studies, please contact us at bhester@acrtampa.com or 813-353-9613.

  • Multiple Sclerosis with walking impairment
  • Flortaucipir F 18 Screening Scans for people with early symptomatic AD
  • Agitation treatment in subjects with Dementia of the Alzheimer’s Type
  • Phase 3 IV treatment for subjects with Early Alzheimer’s
  • Phase 2 IV treatment for subjects with Mild Cognitive Impairment due to Alzheimer’s or Mild Alzheimer’s
  • Phase 2 Combination oral / IV treatment for subjects with early symptomatic Alzheimer’s
  • Observational study for open label Lemtrada for Multiple Sclerosis
  • Phase 2 Injectable for Persistent Posttraumatic Headache

STUDIES IN THE PIPELINE

  • Parkinson’s Phase 2 and 3 trials
  • Alzheimer’s Device
  • Several phase 2/3/4 Multiple Sclerosis